Prednisone alleviates demyelination through regulation of the NLRP3 inflammasome in a C57BL/6 mouse model of cuprizone-induced demyelination
Authors:
- 1 January 2018
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 1678, 75-84
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81271345, 81302519)
- Natural Science Foundation of Jiangsu Province (BK20131132, BK20130221, BK20161174)
This publication has 47 references indexed in Scilit:
- Multiple sclerosis: Therapeutic applications of advancing drug delivery systemsBiomedicine & Pharmacotherapy, 2017
- Control of stress-induced depressive disorders by So-ochim-tang-gamibang, a Korean herbal medicineJournal of Ethnopharmacology, 2017
- Astrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous SystemFrontiers in Aging Neuroscience, 2016
- Walking improvements with nabiximols in patients with multiple sclerosisJournal of Neurology, 2015
- The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insightsMolecular and Cellular Endocrinology, 2011
- Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 miceJournal of Neuroimmunology, 2009
- Behavioral deficits in the cuprizone-induced murine model of demyelination/remyelinationToxicology Letters, 2007
- Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelinationProceedings of the National Academy of Sciences, 2006
- Role of microglia in multiple sclerosisCurrent Neurology and Neuroscience Reports, 2005
- Glial cells express both mineralocorticoid and glucocorticoid receptorsThe Journal of Steroid Biochemistry and Molecular Biology, 1991